Patrick J. Hensley

Updated European Association of Urology (EAU) Prognostic Factor Risk Groups Overestimate the Risk of Progression in Patients with Non–muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin

Niyati Lobo, Patrick J. Hensley, Kelly K. Bree et al. · European Urology Oncology · 2021 · 70 citations · Full text

Urological Research, Urology, Bacillus Calmette-guérin +11

PARP-1 regulates epithelial-mesenchymal transition (EMT) in prostate tumorigenesis

Hong Pu, Craig Horbinski, Patrick J. Hensley et al. · Carcinogenesis · 2014 · 67 citations · Full text

Urology, Genitourinary Cancer, Medicine +13

Contemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with bacillus Calmette-Guérin: Implications for Clinical Trial Design

Justin T. Matulay, Roger Li, Patrick J. Hensley et al. · The Journal of Urology · 2021 · 64 citations

TGF‐β receptor I inhibitor enhances response to enzalutamide in a pre‐clinical model of advanced prostate cancer

Channing J. Paller, Hong Pu, Diane Begemann et al. · The Prostate · 2018 · 63 citations · Full text

Management, Surveillance Patterns, and Costs Associated With Low-Grade Papillary Stage Ta Non–Muscle-Invasive Bladder Cancer Among Older Adults, 2004-2013

Kelly K. Bree, Yong Shan, Patrick J. Hensley et al. · JAMA Network Open · 2022 · 48 citations · Full text